Evidence map›Paper›PMID 31416244›Full record

ReviewInternational journal of molecular sciences2019

Targeting Cellular Metabolism Modulates Head and Neck Oncogenesis.

Yi-Ta Hsieh, Yi-Fen Chen, Shu-Chun Lin, Kuo-Wei Chang, Wan-Chun Li

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Oral Fibrosis and Oral Cancer: From Molecular Targets to Therapeutics.International journal of molecular sciences · 2022
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yi-Ta HsiehInstitute of Oral Biology, School of Dentistry, National Yang-Ming University, Taipei 11221, Taiwan.
Yi-Fen ChenInstitute of Oral Biology, School of Dentistry, National Yang-Ming University, Taipei 11221, Taiwan.ORCID 0000-0001-9177-3647
Shu-Chun LinInstitute of Oral Biology, School of Dentistry, National Yang-Ming University, Taipei 11221, Taiwan.
Kuo-Wei ChangInstitute of Oral Biology, School of Dentistry, National Yang-Ming University, Taipei 11221, Taiwan.
Wan-Chun LiInstitute of Oral Biology, School of Dentistry, National Yang-Ming University, Taipei 11221, Taiwan. wcli@ym.edu.tw.ORCID 0000-0003-0481-4215
National Yang Ming Chiao Tung University · TW

Funding

Ministry of Science and Technology, Taiwan 103-2314-B-010-024-MY3Ministry of Science and Technology, Taiwan 106-2314-B-010-005-MY3Yen Tjing Ling Medical Foundation CI-105-8Yen Tjing Ling Medical Foundation CI-106-13
6 · The paper itself

Abstract

Considering the great energy and biomass demand for cell survival, cancer cells exhibit unique metabolic signatures compared to normal cells. Head and neck squamous cell carcinoma (HNSCC) is one of the most prevalent neoplasms worldwide. Recent findings have shown that environmental challenges, as well as intrinsic metabolic manipulations, could modulate HNSCC experimentally and serve as clinic prognostic indicators, suggesting that a better understanding of dynamic metabolic changes during HNSCC development could be of great benefit for developing adjuvant anti-cancer schemes other than conventional therapies. However, the following questions are still poorly understood: (i) how does metabolic reprogramming occur during HNSCC development? (ii) how does the tumorous milieu contribute to HNSCC tumourigenesis? and (iii) at the molecular level, how do various metabolic cues interact with each other to control the oncogenicity and therapeutic sensitivity of HNSCC? In this review article, the regulatory roles of different metabolic pathways in HNSCC and its microenvironment in controlling the malignancy are therefore discussed in the hope of providing a systemic overview regarding what we knew and how cancer metabolism could be translated for the development of anti-cancer therapeutic reagents.

Indexed as

Energy MetabolismAnimalsAntineoplastic AgentsCarcinoma, Squamous CellCell Transformation, NeoplasticDisease SusceptibilityGene Expression Regulation, NeoplasticHead and Neck NeoplasmsHumansMetabolic Networks and PathwaysMolecular Targeted TherapyAntineoplastic Agentshead and neck cancermetabolic reprogrammingnon-coding RNAtargeted therapytumor microenvironment

Identifiers

PMID31416244
PMCPMC6721038
OpenAlexW2968545499

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.